anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

196,561-196,620 of 319,975

filter-aware
06
Red boxes highlight key clinical history metrics: time since diagnosis, splenectomy history, prior therapies, and concurrent therapy usage.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Agitation1 hit
07
The slide uses a hierarchical testing procedure for statistical significance.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Solution1 hit
08
The chart includes error bars and a table of participant counts at the bottom.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Before-After Comparison1 hit
09
The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Comparative Analysis1 hit
10
The chart uses a back-to-back bar structure to visualize the distribution of disease control duration.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
11
The chart displays point estimates and 95% confidence intervals for the treatment effect across multiple clinical and demographic categories.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Loop · Mece Breakdown1 hit
12
The chart displays a significant, sustained reduction in IgG levels for the treatment group compared to placebo.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
13
The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
14
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
15
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
01
Slide 1
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
02
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
03
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
04
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
05
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Setup1 hit
06
Includes a footer with acronym definitions.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
07
The slide uses a four-column layout to segment strategic focus areas (HER2-high, HR+, gBRCA, TNBC).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
08
The slide uses a timeline framework to establish credibility and future-looking innovation.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
09
The slide uses a horizontal timeline/process flow to map patient treatment stages against therapeutic interventions and resistance mechanisms.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
10
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
11
The slide uses a process flow diagram to illustrate the randomization of patients into treatment arms.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
12
Includes a table of patients at risk below the x-axis and a summary table of PFS events, median PFS, and hazard ratio.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
13
Includes a table of PFS events, median PFS, and adjusted hazard ratio (HR) alongside the survival plot and risk table.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
14
Includes a risk table and summary statistics table (Median PFS, HR).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
15
Includes risk tables and hazard ratios (HR) with 95% confidence intervals.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
16
Includes a forest plot for subgroup analysis and a summary table for prior treatments.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
17
The slide uses a mirrored bar chart to compare adverse event frequencies by grade, alongside a summary table of clinical safety outcomes.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
18
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
19
Includes corporate branding, speaker name/title, and scientific imagery.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
20
The diagram illustrates a randomized clinical trial flow.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
21
The slide presents clinical trial baseline data, likely for a breast cancer study given the markers (ER+, PgR+, ESR1m, CDK4/6i).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
22
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
23
Clinical trial data visualization showing hazard ratios and median PFS.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
24
Clinical trial data visualization showing progression-free survival (PFS) curves with associated hazard ratios and event counts.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
25
The slide uses a split-panel design to compare two patient cohorts (ESR1m detectable vs not detectable).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
26
Clinical trial data visualization showing hazard ratios and median PFS.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
27
The table compares adverse event (AE) frequencies, treatment-related AEs (TRAEs), and dose modifications.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
28
The table lists 15 specific adverse events plus 'Any AE' across 4 cohorts, with two columns per cohort (All grades, Grade >=3).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
29
The slide summarizes the primary outcomes of the SERENA-2 trial, confirming PFS benefits and safety, and mentions ongoing Phase III trials (SERENA-4 and SERENA-6).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & Proof1 hit
30
SABCS stands for San Antonio Breast Cancer Symposium.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
31
Includes Kaplan-Meier survival curve and key efficacy metrics.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
32
Includes a waterfall plot for the BEGONIA trial.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
33
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
34
The slide uses a visual layout with three circular metrics to emphasize the scale of the problem.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Confession1 hit
35
The slide uses a patient journey/treatment pathway framework to map current standard of care against emerging therapeutic interventions.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Confession1 hit
36
Uses a before-after-bridge structure to frame the problem (poor outcomes) and the solution (Capivasertib).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Confession1 hit
37
The slide uses a stacked bar chart to show market share evolution over three quarters and bulleted lists to summarize clinical trial outcomes.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
38
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
39
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
40
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
41
Clinical trial baseline characteristics table.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
42
AstraZeneca | Investor Event Presentation Deck | 42 slidesAstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Azek | Investor Presentation Deck | 37 slidesAzek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
02
Azek | Investor Presentation Deck | 37 slidesAzek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
03
The slide uses a split-layout with a blue sidebar for corporate identity and a large background image of a deck.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
04
The slide serves as a brand and product catalog overview.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
05
The slide uses a structured list format to present four core pillars of the business strategy.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
06
The slide combines financial performance charts with a company overview and key operational metrics.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations 1 hit
07
Includes a callout regarding architect popularity and a note on the replacement cycle of existing decks.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a before-and-after visual comparison for decking and specific conversion percentages for trim and railing.Azek | Investor Presentation Deck | 37 slides · Azek
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit